CDKN2A and lung cancer: Epigenetic Indicators for Early Detection of Lung Cancer: Hypermethylation of genes like RARB, CDKN2A, and MGMT have emerged as promising biomarkers for lung cancer early detection, prognosis, and prediction of therapeutic response [98].